| Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study AE Grulich, R Guy, J Amin, F Jin, C Selvey, J Holden, HMA Schmidt, ... The lancet HIV 5 (11), e629-e637, 2018 | 336 | 2018 |
| Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study R Schaefer, HMA Schmidt, G Ravasi, A Mozalevskis, BB Rewari, F Lule, ... The Lancet HIV 8 (8), e502-e510, 2021 | 85 | 2021 |
| The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease … HMA Schmidt, S Andres, NO Kaakoush, L Engstrand, L Eriksson, KL Goh, ... Gut pathogens 1, 1-8, 2009 | 71 | 2009 |
| A widening gap? Changes in multiple lifestyle risk behaviours by socioeconomic status in New South Wales, Australia, 2002–2012 D Ding, A Do, HM Schmidt, AE Bauman PloS one 10 (8), e0135338, 2015 | 69 | 2015 |
| Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial IB Zablotska, C Selvey, R Guy, K Price, J Holden, HM Schmidt, A McNulty, ... BMC public health 18, 1-10, 2018 | 63 | 2018 |
| Distinct cagA EPIYA Motifs are Associated with Ethnic Diversity in Malaysia and Singapore HMA Schmidt, KL Goh, KM Fock, I Hilmi, S Dhamodaran, D Forman, ... Helicobacter 14 (4), 256-263, 2009 | 63 | 2009 |
| The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore HMA Schmidt, S Andres, C Nilsson, Z Kovach, NO Kaakoush, L Engstrand, ... European journal of clinical microbiology & infectious diseases 29, 439-451, 2010 | 53 | 2010 |
| Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi‐ethnic country HMA Schmidt, DM Ha, EF Taylor, Z Kovach, KL Goh, KM Fock, JH Barrett, ... Journal of gastroenterology and hepatology 26 (12), 1725-1732, 2011 | 46 | 2011 |
| Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre … AE Grulich, R Guy, J Amin, F Jin, C Selvey, J Holden, HA Schmidt, ... Lancet HIV 5 (11), e629-e637, 2018 | 44 | 2018 |
| Nurse-led pre-exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial HMA Schmidt, R McIver, R Houghton, C Selvey, A McNulty, R Varma, ... Sexual Health 15 (6), 595-597, 2018 | 36 | 2018 |
| Rising chlamydia and gonorrhoea incidence and associated risk factors among female sex workers in Australia: a retrospective cohort study D Callander, H McManus, R Guy, M Hellard, CC O’Connor, CK Fairley, ... Sexually transmitted diseases 45 (3), 199-206, 2018 | 36 | 2018 |
| Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011–2015 M Holt, T Lea, HM Schmidt, J Kolstee, J Ellard, D Murphy, HH Truong, ... Sexually transmitted infections 93 (6), 438-444, 2017 | 36 | 2017 |
| The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90‐90‐90 targets P Keen, RT Gray, B Telfer, R Guy, HM Schmidt, B Whittaker, J Holden, ... Journal of the International AIDS Society 21 (4), e25109, 2018 | 33 | 2018 |
| Increasing belief in the effectiveness of HIV treatment as prevention: results of repeated, national surveys of Australian gay and bisexual men, 2013–15 M Holt, T Lea, HM Schmidt, D Murphy, M Rosengarten, D Crawford, ... AIDS and Behavior 20, 1564-1571, 2016 | 33 | 2016 |
| Helicobacter pylori defines local immune response through interaction with dendritic cells S Andres, HMA Schmidt, H Mitchell, M Rhen, M Maeurer, L Engstrand FEMS Immunology & Medical Microbiology 61 (2), 168-178, 2011 | 32 | 2011 |
| Rapid reduction in HIV diagnoses after targeted PrEP implementation in NSW, Australia A Grulich, RJ Guy, J Amin, H Schmidt, C Selvey, J Holden, K Price, ... 25th Conference on Retroviruses and Opportunistic Infections (CROI), 2018 | 30 | 2018 |
| Preferences for pre-exposure prophylaxis for HIV: a systematic review of discrete choice experiments LPL Wulandari, SY He, CK Fairley, BR Bavinton, HM Schmidt, V Wiseman, ... EClinicalMedicine 51, 2022 | 20 | 2022 |
| Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice HMA Schmidt, M Rodolph, R Schaefer, R Baggaley, M Doherty African Journal of Reproduction and Gynaecological Endoscopy 25 (7), e25963, 2022 | 20 | 2022 |
| Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job? HMA Schmidt, R Schaefer, M Radebe, O Sued, M Rodolph, N Ford, ... The Lancet HIV 9 (5), e363-e366, 2022 | 20 | 2022 |
| Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition VA Fonner, K Ridgeway, A Van Der Straten, L Lorenzetti, N Dinh, ... Aids 37 (6), 957-966, 2023 | 19 | 2023 |
